超氧化物歧化酶
化学
抗氧化剂
氧化应激
激进的
歧化酶
体重
过氧化氢酶
生物化学
药理学
动物科学
内分泌学
生物
作者
Arsiaty,Yulia Delfahedah,Andre Bastian Manik,Nurasima Kurniati Damanik
出处
期刊:International Journal Of Public Health Excellence
[PT Inovasi Pratama Internasional]
日期:2022-05-30
卷期号:1 (2): 237-240
标识
DOI:10.55299/ijphe.v1i2.330
摘要
Free radicals are compounds or molecules that contain one or more unpaired electrons in their outer orbitals. If the production of free radicals is excessive, it can cause oxidative damage which ends in cell death resulting in the acceleration of various degenerative diseases. To neutralize the work of free radicals, external antioxidants are needed. Andaliman (Zanthoxylum acanthopodium DC) is a source of natural antioxidants that contain flavonoids that can neutralize free radicals. This research included sample preparation, examination of simplicia characteristics, screening of simplicia phytochemicals, extract preparation, determination of SOD activity spectrophotometrically using reagents. A total of 30 rats were divided into 6 groups consisting of the control group, the stress-induced group, the comparison group, and the three stress-induced and EEBA groups with doses of 75 mg/kg, 150 mg/kg, and 300 mg respectively. /kg bw. Stress induction was carried out by administering EEBA for 7 days and continued by administering EEBA together with doxorubicin for the next 2 days. The results showed that the average SOD level in the control group was (4.626 0.2583), the doxorubicin group (1.956+ 0.0879), the EEBA group 75 mg kg body weight (2.444 0.0844), the EEBA group 150 mg/kg body weight ( 3.052 +0.1139), the EEBA 300 mg/kg body weight (3.646+0.1739) and the Routine 50 mg/kg body weight 5.594 + 0.2056), EEBA had higher SOD activity when compared to the doxorubicin group. Based on the statistical results, SOD activity increased with the increase in the dose of EEBA given and showed a significant difference (p<0.05) between the EPBA group and the doxorubicin group. Observations on liver tissue in the group given EEBA showed better conditions than the liver in the doxorubicin group.
科研通智能强力驱动
Strongly Powered by AbleSci AI